Meiji Yasuda Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-64,492
Closed -$899K – 610
2023
Q3
$899K Sell
64,492
-617
-0.9% -$7.89K 0.04% 340
2023
Q2
$766K Hold
65,109
– – 0.04% 327
2023
Q1
$749K Hold
65,109
– – 0.04% 330
2022
Q4
$809K Hold
65,109
– – 0.04% 346
2022
Q3
$854K Buy
65,109
+417
+0.6% +$6.16K 0.05% 326
2022
Q2
$904K Buy
64,692
+24,630
+61% +$329K 0.05% 341
2022
Q1
$597K Buy
+40,062
New +$548K 0.03% 420

Other funds holding SBRA

Meiji Yasuda Asset Management's SBRA Position: Q4 2023 in Review

Meiji Yasuda Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 64,492 shares — an estimated $899K sold.

Meiji Yasuda Asset Management first reported a position in SBRA in Q1 2022 and held it in 7 quarters. The position peaked at $904K in Q2 2022. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • Meiji Yasuda Asset Management reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • Meiji Yasuda Asset Management sold 64,492 Sabra Healthcare REIT shares in Q4 2023, an estimated $899K.
  • Meiji Yasuda Asset Management first reported a position in Sabra Healthcare REIT in Q1 2022 and held it in 7 quarters.
  • Meiji Yasuda Asset Management's Sabra Healthcare REIT position peaked at $904K in Q2 2022.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Meiji Yasuda Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.